NDAINJECTIONINJECTABLE
Approved
Feb 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 11h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Netromycin (netilmicin sulfate) is an aminoglycoside antibiotic administered via injection for treatment of serious gram-negative bacterial infections. It is a semisynthetic derivative designed to overcome resistance mechanisms seen with earlier aminoglycosides. The drug works by inhibiting bacterial protein synthesis through ribosomal binding.
LOE Approaching
With LOE approaching and moderate competitive pressure (30%), career roles will shift toward optimization and managed decline rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked jobs and LOE approaching, career opportunities on Netromycin are limited and focused on defensive market management rather than growth. Professionals in hospital sales, market access, or medical affairs may find roles, but team sizes are likely contracting.
Hospital Account ManagerAntibiotic Specialty Sales
Worked on NETROMYCIN at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.